Drug Shortage Report for TRULICITY

Last updated on 2024-03-20 History
Report ID 211401
Drug Identification Number 02448599
Brand name TRULICITY
Common or Proper name dulaglutide
Company Name ELI LILLY CANADA INC
Market Status MARKETED
Active Ingredient(s) DULAGLUTIDE
Strength(s) 0.75MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 4 x 0.5 mL single-use prefilled pen
ATC code A10BJ
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Demand increase for the drug.
Anticipated start date 2023-11-30
Actual start date 2023-11-30
Estimated end date 2024-05-31
Actual end date
Shortage status Actual shortage
Updated date 2024-03-20
Company comments Due to continued demand an allocation strategy has been implemented. The estimated end date represents projected availability at the main Lilly warehouse. Availability dates at a pharmacy’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their distributor to obtain the product availability date at the distributor, or to contact our Lilly Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays) for more information.
Health Canada comments
Tier 3 Status No
Contact Address EXCHANGE TOWER, 130 KING STREET WEST
TORONTO, ONTARIO
CANADA M5X 1B1
Company contact information Lilly Canada’s Customer Response Centre 1-888-545-5972.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2024-03-20 French Compare
v8 2024-03-20 English Compare
v7 2024-01-04 French Compare
v6 2024-01-04 English Compare
v5 2023-12-01 English Compare
v4 2023-11-30 French Compare
v3 2023-11-30 English Compare
v2 2023-11-24 French Compare
v1 2023-11-24 English Compare

Showing 1 to 9 of 9